• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchMineralys Therapeutics
    Picture of Mineralys Therapeutics logo

    MLYS — Mineralys Therapeutics Share News

    $21.640.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapSucker Stock
    • Market Cap
      $1.91bn
    • Enterprise Value
      $1.35bn
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • MLYS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    MLYS Dividends
    • Brief: Mineralys Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update

      15/05/2023 21:30
    • Brief: Mineralys Therapeutics Inc Says Topline Data From Trial Are Expected In First Half Of 2024

      02/05/2023 13:51
    • U.S. RESEARCH ROUNDUP-Adobe, Five Below, Lennar

      16/03/2023 07:29
    • Brief: Mineralys Therapeutics Reports Q4 And Full Year 2022 Financial Results And Provides Corporate Update

      15/03/2023 20:02
    • U.S. STOCKS ON THE MOVE-BlackSky, Squarespace, Virax Biolabs

      07/03/2023 14:22
    • Credit Suisse initiates coverage on Mineralys with 'outperform' rating

      07/03/2023 13:44
    • Brief: Mineralys Therapeutics Says Positive Lorundrostat Results From The Phase 2 Target-Htn Trial At ACC.23/Wcc

      04/03/2023 21:32
    • Brief: Mineralys Therapeutics Announces Closing Of Initial Public Offering

      14/02/2023 21:32
    • Brief: Mineralys Therapeutics Shares Open 31.9% Above IPO Price In Nasdaq Debut

      10/02/2023 16:18
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.